An Israeli drug company plans to purchase an American producer for $7.5 billion.
Teva Pharmaceuticals announced Friday its intention to purchase New Jersey-based Barr Pharmaceuticals in a purchase that, if completed, would be the largest ever by an Israeli company, Ha’aretz reported.
The $7.5 billion price tag is 44 percent above Barr’s market value. Teva is the largest generic drug maker in the world.
Reporting the stories that define our era. When history unfolds in real-time, the Jewish world turns to JTA. Your support ensures we can document the complexities of war and the resilience of Jewish communities with integrity.